ISRCTN63499520已完成不适用
Randomised comparison of cyclical anthracyline-based chemotherapy [PA(B1)OE] with alternating chemotherapy [Ch1VPP/PABLOE] in advanced Hodgkin's disease
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Previously untreated and properly stage patients with Hodgkin's disease for whom chemotherapy is indicated, ie stage I and IIA (poor prognosis), IB, IIB, III and IV
- •2. Patients must be free from any irreversible medical condition that would drastically limit their life span or prohibit use of combination chemotherapy
- •3. Aged 15 to 69 years inclusive
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
Randomised Comparison of Cyclical Anthracycline-Based Chemotherapy [PA(BI)OE] with Alternating Chemotherapy [ChlVPP/PABIOE] in Advanced Hodgkin's Diseaseymphoma (Hodgkin's)Lymphoma (Hodgkin's)CancerISRCTN46778796British National Lymphoma Investigation (BNLI) (UK)
已完成
3 期
Randomized study of anthracycline vs. TS-1 in patients with metastatic or recurrent breast cancerMetastatic or recurrent breast cancerJPRN-UMIN000005449SELECT BC-CONFIRM executive committee200
已完成
2 期
A feasibility study of sequential Anthracycline-based regimen and Nab-Paclitaxel / Trastuzumab followed by Trastuzumab as postoperative adjuvant chemotherapy for Her2 positive breast cancer.(SBCCSG-22)Primary breast cancerJPRN-UMIN000006085Saitama Breast Cancer Clinical Study Group(SBCCSG)30
进行中（未招募）
1 期
Primary comparison of therapies before stem cell transplantation in patients with higher risk MDS and oligoblastic AMntreated patients with higher risk MDS and oligoblastic AML eligible and intended for allogeneic HCT within the next 6 monthsMedDRA version: 21.0Level: LLTClassification code 10000886Term: Acute myeloid leukemiaSystem Organ Class: 100000004864MedDRA version: 20.0Level: HLTClassification code 10028536Term: Myelodysplastic syndromesSystem Organ Class: 100000004851EUCTR2018-002430-21-ATGWT-TUD GmbH20
进行中（未招募）
1 期
Primary comparison of therapies before stem cell transplantation in patients with higher risk MDS and oligoblastic AMEUCTR2018-002430-21-DEGWT-TUD GmbH150